Next Article in Journal
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8
Previous Article in Journal
Effect of Solute Concentration and Filtration Rate on the Scale Production of a Physically Stable Amorphous Solid Form of Nilotinib
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Khalid et al. Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation. Pharmaceutics 2025, 17, 483

1
Department of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia
2
Universiti Malaya-Research Centre for Biopharmaceuticals and Advanced Therapeutics (UBAT), Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia
3
Centre of Advanced Materials (CAM), Faculty of Engineering, Universiti Malaya, Kuala Lumpur 50603, Malaysia
4
School of Pharmacy, Queen’s University Belfast, Belfast BT9 7BL, UK
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2025, 17(8), 1001; https://doi.org/10.3390/pharmaceutics17081001
Submission received: 29 July 2025 / Accepted: 29 July 2025 / Published: 31 July 2025

Figure Legend

In the original publication [1], there was a mistake in the legend for Figure S3. The original Figure S3 displayed a 3D response surface and contour plot related to zeta potential, but it was intended to show the impact of variables on the entrapment efficiency of VAL-LP (Supplementary Material). The correct legend appears below.
  • Figure S3. Independent variable’s comparative impact on entrapment efficiency of VAL-LP by 3D response surface and contour plot.

Error in Figure

In the original publication [1], there was a mistake in Figure S9. The subfigure labeled “FD-LIPO-DMNs” was mistakenly included in Figure S9. This subfigure does not represent data relevant to the current study and was included by mistake (Supplementary Material). The correct Figure S9 appears below.
Figure S9. Digital images of parafilm layers showing the insertion of optimized VAL-LP-DMNs (magnification 2×).
Figure S9. Digital images of parafilm layers showing the insertion of optimized VAL-LP-DMNs (magnification 2×).
Pharmaceutics 17 01001 g001
There was a mistake in Figure S3 as published. The original Figure S3 displayed a 3D response surface and contour plot related to zeta potential, but it was intended to show the impact of variables on the entrapment efficiency of VAL-LP (Supplementary Material). The corrected Figure S3 appears below.
Figure S3. Independent variable’s comparative impact on entrapment efficiency of VAL-LP by 3D response surface and contour plot.
Figure S3. Independent variable’s comparative impact on entrapment efficiency of VAL-LP by 3D response surface and contour plot.
Pharmaceutics 17 01001 g002
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Khalid, R.; Mahmood, S.; Mohamed Sofian, Z.; Chik, Z.; Ge, Y. Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation. Pharmaceutics 2025, 17, 483. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Khalid, R.; Mahmood, S.; Mohamed Sofian, Z.; Chik, Z.; Ge, Y. Correction: Khalid et al. Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation. Pharmaceutics 2025, 17, 483. Pharmaceutics 2025, 17, 1001. https://doi.org/10.3390/pharmaceutics17081001

AMA Style

Khalid R, Mahmood S, Mohamed Sofian Z, Chik Z, Ge Y. Correction: Khalid et al. Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation. Pharmaceutics 2025, 17, 483. Pharmaceutics. 2025; 17(8):1001. https://doi.org/10.3390/pharmaceutics17081001

Chicago/Turabian Style

Khalid, Ramsha, Syed Mahmood, Zarif Mohamed Sofian, Zamri Chik, and Yi Ge. 2025. "Correction: Khalid et al. Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation. Pharmaceutics 2025, 17, 483" Pharmaceutics 17, no. 8: 1001. https://doi.org/10.3390/pharmaceutics17081001

APA Style

Khalid, R., Mahmood, S., Mohamed Sofian, Z., Chik, Z., & Ge, Y. (2025). Correction: Khalid et al. Development of Rapidly Dissolving Microneedles Integrated with Valsartan-Loaded Nanoliposomes for Transdermal Drug Delivery: In Vitro and Ex Vivo Evaluation. Pharmaceutics 2025, 17, 483. Pharmaceutics, 17(8), 1001. https://doi.org/10.3390/pharmaceutics17081001

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop